Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Active vs. Passive VR During Office-based ENT Procedures

NCT: NCT07599826 · NOT_YET_RECRUITING

NCT IDNCT07599826
StatusNOT_YET_RECRUITING
Start Date2026-06
Completion2027-12

Brief Summary

The purpose of this research is to evaluate whether active virtual reality reduces pain and anxiety more effectively than passive virtual reality during office-based ENT procedures. The main procedures include exposure to virtual reality (passive calming scenery or interactive puzzle game) via Paperplane Therapeutics software with VR headset or glasses during common in-office ENT procedures, participant self-report surveys (GAD-7, PHQ-9, PEG, VAS, SUDS, Likert, experience questions), and physician post-procedure survey. The study will enroll individuals 18 years or older who are scheduled to undergo common office-based ENT procedures (turbinate reduction, nasal debridement, balloon sinuplasty, radiofrequency ablation, nasal polypectomy, eustachian tube dilation, vocal fold injection, or subglottic steroid injection) at Cedars Sinai.

Frequently Asked Questions

What is Active vs. Passive VR During Office-based ENT Procedures?

Active vs. Passive VR During Office-based ENT Procedures is a clinical trial registered under NCT07599826. Current status: NOT_YET_RECRUITING.

What is the status of NCT07599826?

The current status of NCT07599826 (Active vs. Passive VR During Office-based ENT Procedures) is: NOT_YET_RECRUITING.

When did Active vs. Passive VR During Office-based ENT Procedures start?

Active vs. Passive VR During Office-based ENT Procedures started on 2026-06.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.